FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma.

已完结 20 由达姆发布于 2026/9/9 9:10:45

DOI:10.1158/0008-5472.CAN-23-0966
作者：Jiao Huang,?Wai Ying Tsang,?Xiao-Na Fang,?Yu Zhang,?Jie Luo,?Lan-Qi Gong,?Bai-Feng Zhang,?Ching Ngar Wong,?Zhi-Hong Li,?Bei-Lei Liu,?Jin-Lin Huang,?Yu-Ma Yang,?Shan Liu,?Liu-Xian Ban,?Yiu Hong Chan,?X
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：Immune checkpoint inhibitors (ICI) transformed the treatment landscape of hepatocellular carcinoma (HCC). Unfortunately, patients with attenuated MHC-I expression remain refractory to ICIs,

应助信息

14小时前

Book学术机器人

27f8949f507f11ef955834735aa3bc31.pdf 已采纳

14小时前

Book学术机器人

2026/9/9 9:10:45 Book学术AI机器人已找到文献并上传

2026/9/9 9:10:45 Book学术AI机器人收到请求，开始寻找文献

2026/9/9 9:10:45 已向机器人发送请求

14小时前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Explainable Machine Learning and Deep Learning Models for Understanding Operational and Degradation Effects in Nafion Membranes